Groups and research environments within the network that perform research in prevention, diagnostic tools, and therapy of cardiovascular diseases in patients.
If you would like your research group featured here, please contact Jacob Fog Bentzon.
We focus on development and application of MR based methods for examining the cardiac muscle, flow patterns in the heart and vessels, and metabolism of the myocardium. This is obtained partly by applying traditional methods based on proton MR and more advanced methods based on other nuclei and hyperpolarized MR. The research spans from basic experiments in small animals and pigs to human studies in volunteers and patients. Examples are projects for measuring flow patterns around artificial heart valves, development of methods for distinguishing damaged myocardium from healthy and studies of cardiac energy metabolism using hyperpolarized MR.
Key research methods
Please contact Christoffer Laustsen for more information
Our research group focuses on Cardiac Rehabilitation in primary healthcare centres with a focus on Phase II Cardiac Rehabilitation and the links to hospital and phase III.
Our research focuses on Cardiac Rehabilitation in the municipality healthcare centres.
We hold a special interest in a range of factors that influence Phase II Cardiac Rehabilitation such as
We are also interested in the organization of health care that influence the course of cardiac rehabilitation and health of patients with CVD. We explore how initiatives to prevent inequality in health and better course of rehabilitation are best implemented.
How do municipality healthcare centres deliver the right care to the right patients at the right time in the most efficient way.
Key research methods
Contact professor Thomas Maribo for more information.
Our research aims at exploring mechanisms and treatment of cardiovascular thrombosis, including acute & chronic coronary syndromes, venous thrombosis and atrial fibrillation. Most emphasis is on antithrombotic therapy, but the project portfolio also includes studies on pathophysiology and diagnostic markers of thrombosis. Also, novel drugs for treatment of e.g. heart failure, hyperlipidemia and diabetes are evaluated.
Key research methods
Contact Erik Lerkevang Grove, Anne-Mette Hvas or Steen Dalby Kristensen for more information.
In a research environment integrated with clinical patient treatment, we focus on improving outcomes in patients with cardiac arrhythmia and patients treated with cardiac implantable electronic devices (CIED) as well as preventing sudden death from arrhythmia. Furthermore, we perform studies improving the understanding of the effects of CIED-therapy and catheter ablation.
Main areas and methods
Contact Jens Cosedis Nielsen for more information.
Our research focus on the integrated treatment of patients with atrial fibrillation. From screening to treatment incl. patient education og empowerment followed by rehabilitation. We focus on interventions incl. telemedicine.
Key research methods
Contact Andi Eie Albertsen, MD, PhD for more information.
Our research group focuses on handling of patients with CVD in general practice, in particular, we have focus on multimorbidity and mental health.
Our research focuses on patients with CVD from prevention, treatment and rehabilitations. This course includes a range of phases and factors that influence how general practice can play an important role in helping patients to a good life with CVD, by delivering the right care to the right patients at the right time in the most efficient way.
We are also interested in the mechanisms of clinicians and in the organization of health care that influence clinical behavior. We explore how these mechanisms are affected and how new initiatives are best implemented.
Key research methods
Contact Bo Christensen for more information.
Our research group main focus is heart failure, type 2 diabetes, metabolism and imaging. We are curiously investigating new treatment modalities to optimize the cardiac performance in patients with heart failure. We perform randomized controlled clinical trials in order to investigate the different interventions. The outcomes are assessed with imaging modalities such as PET-scanning, MRI, advanced echocardiography or by invasive hemodynamic measurements.
Key research methods
Contact Henrik Wiggers for more information.
- translational research into inherited heart diseases and sudden cardiac death
In a translational research collaboration we are introducing precision medicine into the diagnosis and treatment of inherited heart diseases and sudden cardiac death to improve stratification and timing of health care. This enables exact diagnoses, identification of family members at risk and establishment of treatment to prevent sudden cardiac death especially in children, adolescents and younger adults.
Main areas
Translational research collaboration with (1) Department of Molecular Medicine, Aarhus University Hospital, (2) Department of Biomedicine, Health, Aarhus University, (3) Department of Molecular Biology and Genetics, Aarhus University, (4) Department of Forensic Medicine, Aarhus University and (5) Department of Public Health, Aarhus University.
Contact Henrik Kjærulf Jensen for more information
We use molecular imaging by PET to measure myocardial perfusion, substrate metabolism and oxygen consumption. Since PET is non-invasive, both patients and healthy individuals can be investigated with minimal perturbation of naturally occurring substrate metabolism. Our aim is to investigate the adaptive and maladaptive cardiac processes caused by metabolic diseases such as diabetes and heart failure, and to investigate the beneficial effects of pharmacological and non-pharmacological cardiac interventions. Combining functional information from PET with morphological information by MRI on our hybrid PET/MRI system enables us to more precisely characterize mechanical cardiac dysfunction.
Key research methods
Contact Lars Christian Gormsen for more information
Main research topics
Key research methods
Contact Hans Eiskjær for more information.